Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antivirals.

Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antivirals.

<h4>Background/aims</h4>Undetectable HCV RNA 12 weeks after the end of treatment (SVR12) has been the valid efficacy endpoint in the era of direct-acting antivirals (DAAs). Its concordance with SVR4 and SVR24 and long-term durability is unknown in Taiwanese chronic hepatitis C (CHC) pati...

Full description

Bibliographic Details
Main Authors: Chuan-Pin Lin, Po-Cheng Liang, Ching-I Huang, Ming-Lun Yeh, Po-Yao Hsu, Cheng-Ting Hsu, Yu-Ju Wei, Ta-Wei Liu, Ming-Yen Hsieh, Nai-Jen Hou, Tyng-Yuang Jang, Yi-Hung Lin, Chih-Wen Wang, Zu-Yau Lin, Shinn-Cherng Chen, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0245479

Internet

https://doi.org/10.1371/journal.pone.0245479

Similar Items